Join
Live feed
·
PRReleasevia Quantisnow
Nurix Therapeutics Inc. logo

Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences

ByQuantisnow·Wall Street's wire, on your screen.
NRIX· Nurix Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NRIX (Nurix Therapeutics Inc.) and more on Quantisnow.